Pharmaceuticals - Union Register

  

Register of orphan medicinal products


GRANTED  

Product information

Eculizumab

EU orphan designation number: EU/3/13/1185   
Active ingredient: Eculizumab
Indication: Treatment of neuromyelitis optica
Sponsor: Alexion Europe SAS
1-15 avenue Edouard Belin, 92500 Rueil-Malmaison, France

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
8/08/2013 Orphan designation EMA/OD/087/13 (2013)5284 of 5/08/2013
20/02/2015 Change of name and/or address of sponsor